Protara Therapeutics earnings were -$44.6M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest TARA earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$12.8M, up 13.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TARA reported annual earnings of -$44.6M, with 10.3% growth. The next TARA earnings date is Apr 30, 2025.
Protara Therapeutics Earnings Reports & History FAQ
What were Protara Therapeutics's earnings last quarter?
On TARA's earnings call on Invalid Date, Protara Therapeutics (NASDAQ: TARA) reported Q4 2024 earnings per share (EPS) of -$0.43, up 52.22% year over year. Total TARA earnings for the quarter were -$12.77 million. In the same quarter last year, Protara Therapeutics's earnings per share (EPS) was -$0.90.
The next TARA earnings date is Invalid Date. Add TARA to your watchlist to be reminded of Protara Therapeutics's next earnings date.
What was TARA's earnings growth in the past year?
As of Protara Therapeutics's earnings date in Invalid Date, Protara Therapeutics's earnings has grown year over year. TARA earnings in the past year totalled -$44.60 million.
Is Protara Therapeutics profitable or losing money?
As of the last Protara Therapeutics earnings report, Protara Therapeutics is currently losing money. Protara Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$44.60 million, a 10.33% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.